<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Examples of drugs known to be safe or unsafe in the acute porphyrias</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Examples of drugs known to be safe or unsafe in the acute porphyrias</h1>
<div class="graphic"><div class="figure"><div class="ttl">Examples of drugs known to be safe or unsafe in the acute porphyrias</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="3">Safe</td> </tr> <tr> <td class="indent1"> <p>Acetaminophen (paracetamol)</p> <p>Aminoglycosides</p> <p>Anesthetic (eg, propofol)</p> <p>Antiemetics* (ondansetron); refer to note</p> <p>Aspirin</p> <p>Atropine</p> Benzodiazepines<sup>¶</sup> (eg, lorazepam, midazolam); refer to note</td> <td> <p>Cephalosporins; refer to note</p> <p>Erythropoietin<sup>Δ</sup></p> <p>Gabapentin</p> <p>Glucocorticoids</p> <p>Histamine<sub>2</sub> receptor antagonists<sup>Δ</sup> (eg, cimetidine, famotidine)</p> <p>Insulin</p> Levetiracetam</td> <td> <p>Local anesthetics<sup>¶</sup> (eg, lidocaine, bupivacaine)</p> <p>Opioid analgesics<sup>¶</sup></p> <p>Penicillin and derivatives</p> <p>Phenothiazines (eg, chlorpromazine, prochlorperazine, promethazine)</p> <p>Proton pump inhibitors (eg, lansoprazole, omeprazole, pantoprazole)</p> Vigabatrin</td> </tr> <tr> <td class="subtitle1_left" colspan="3">Unsafe</td> </tr> <tr> <td class="indent1"> <p>Alcohol</p> <p>Anesthetics<sup>¶</sup> (eg, etomidate, ketamine, thiopental)</p> <p>Antipyrine (phenazone)</p> <p>Barbiturates<sup>Δ</sup></p> <p>Carbamazepine<sup>Δ</sup></p> <p>Carisoprodol<sup>Δ</sup></p> <p>Clonazepam (high doses)</p> <p>Danazol<sup>Δ</sup></p> <p>Diclofenac<sup>Δ</sup> and possibly other NSAIDs</p> <p>Efavirenz</p> <p>Ergot derivatives (including dihydroergotamine)</p> Estrogens<sup>Δ</sup></td> <td> <p>Ethosuximide and methsuximide</p> <p>Griseofulvin<sup>Δ</sup></p> <p>Hydralazine</p> <p>Hydroxyzine</p> <p>Meprobamate<sup>Δ</sup></p> <p>Nifedipine</p> <p>Nitrofurantoin</p> <p>Oxcarbazepine</p> <p>Pentazocine</p> <p>Phenytoin<sup>Δ</sup></p> Phenobarbital<sup>Δ</sup></td> <td> <p>Primidone<sup>Δ</sup></p> <p>Progesterone and synthetic progestins<sup>Δ</sup></p> <p>Pyrazinamide<sup>Δ</sup></p> <p>Rifampin<sup>Δ</sup></p> <p>Spironolactone</p> <p>Sulfasalazine</p> <p>Sulfonamide antibiotics<sup>Δ</sup> (including trimethoprim-sulfamethoxazole [cotrimoxazole])</p> <p>Tamoxifen</p> <p>Topiramate</p> Valproic acid<sup>Δ</sup></td> </tr> </tbody></table></div><div class="graphic_lgnd"><p>This table includes examples of commonly used drugs known to be safe or unsafe in the acute porphyrias (ie, porphyrias associated with acute neurovisceral attacks).</p>
    
    NOTE: <strong>This list is incomplete and includes drugs for which there is general agreement among experts.</strong> It is recommended that clinicians consult the websites of the <a href="https://porphyriafoundation.org/" target="_blank">American Porphyria Foundation</a> and the <a href="https://porphyrianet.org/en/content/worldwide-network" target="_blank">International Porphyria Network</a>, which are frequently updated; list many other drugs, including those that are not classified with certainty; and provide evidence for these classifications. Because the evidence base is inadequate, expert assessments of the safety of drugs in porphyria may differ. Refer to the UpToDate topics on individual porphyrias for more information.</div><div class="graphic_footnotes"><p>NSAIDs: nonsteroidal antiinflammatory drugs.</p>
<p>* Serotonin 5HT3 antagonists are probably safe. Classification of metoclopramide is controversial but is generally a less effective antiemetic.</p>
<p>¶ Not all agents within the same class will necessarily have the same risk. For example, though opioids are generally considered safe, pentazocine may be unsafe. Benzodiazepines that are rapidly metabolized or administered in low doses are considered safe, but the safety of high doses or prolonged use of long-acting agents is less certain. There are conflicting reports on the safety of cephalosporins.</p>
    
    Δ In United States labeling for these drugs, porphyria is listed as a contraindication, warning, precaution, or adverse effect. Erythropoietin is regarded as safe by other sources. Estrogens are unsafe for porphyria cutanea tarda but can be used with caution in the acute porphyrias, especially in low doses or by the transdermal route.</div><div class="graphic_reference">Adapted from: Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005; 142:439.</div><div id="graphicVersion">Graphic 57422 Version 21.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
